Warren, NJ 7/17/14—Roka Bioscience, a provider of testing solutions for detecting foodborne pathogens, has completed its IPO (see IBO 5/31/14, 7/15/14), offering five million shares at a price of $12.00 per share. Shares began trading on the NASDAQ Global Market on July 17 under the ticker symbol “ROKA.” The company has granted the underwriters a […]
San Diego, CA 7/16/14—Illumina has purchased Myraqa, a regulatory and quality consulting firm that specializes in IVD, particularly companion diagnostics. The purchase price was undisclosed. Illumina stated that the acquisition adds to its in-house capabilities for clinical readiness and prepares it for its next growth phase in regulated markets. “With Myraqa, Illumina will continue to […]
Washington, DC 7/23/14—Bruker has announced in an SEC filing that it plans to divest certain assets of its Chemical & Applied Markets Division (CAM) and restructure the unit. In 2013, CAM had revenues of $100 million. Bruker stated that it plans to divest or restructure CAM’s GC product lines, including its single-quadrupole GC and GC/MS […]
Waltham, MA 7/17/14; Chicago, IL 7/17/14—Private-equity firm GTCR has agreed to buy Thermo Fisher Scientific’s Cole-Parmer Instrument business (see IBO 5/31/14), part of its Laboratory Products and Services Segment, for $480 million in cash. Based in Illinois with 400 employees, Cole-Parmer is a manufacturer and distributor of laboratory supplies, specializing in fluid-handling, test and measurement, […]
Now with the first six months of 2014 in the history books, it is appropriate to estimate how the remainder of the year will develop, and importantly, how the current full-year estimates match with IBO’s original forecast (see IBO 1/15/14). In January, our industry forecast was based on the previous year’s results without the benefit […]
Company Announcements Ibidi announced in March a collaboration with SiMPore to develop live-cell imaging tools combining their respective Cell Biochips and G-Flat Microporous Glass Membranes to create bio-slides. Sysmex entered into a clinical-research, licensing and joint-development agreement with Merck Millipore to use Millipore’s imaging flow cytometry technology for the creation of diagnostic tools for hematologic […]
Company Announcements Repligen’s 2013 Bioprocessing Product sales increased 13.5% to $47.5 million to make up 70% of total revenues. Novasep’s 2013 Synthesis sales grew 5.2% to €155.1 million ($206.8 million) to make up 49% of revenues. In April, FloDesign Sonics, a developer of core acoustic separation technology for bioprocessing, closed a $10 million Series A […]
As a semiregular feature, IBO highlights funding announcements that are expected to drive investment in analytical instruments and laboratory products. This installment includes announcements by two firms and the UK government. IBM announced this month a five-year, $3 billion investment to develop the next generation of semiconductor-chip technology. One project is “7 nanometer and beyond […]
With all companies in the IBO Laboratory Sales Index having reported first quarter financials except for Spectris and Tecan, Index figures have been updated from the May 15 issue. First quarter Index sales expanded 6.9%, 6.7% excluding currency, to $6,286 million. Adjusted operating profit advanced 12.8% to $1,366 million, primarily due to strong results from […]
Company Announcements Personal Genomics announced in April an exclusive sales alliance for Knome’s knoSYS platform in Italy. Under a distribution agreement, Bina Technologies will include runtime licenses for Appistry’s Genome Analysis Toolkit and Cancer Genome Analysis Suite analysis tools as part of its Bina Analytical genomics platform. First quarter Pacific Biosciences sales soared 108.7% to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
